← Back to Search

Behavioral Intervention

Video Intervention for Depression and Anxiety

N/A
Recruiting
Led By Aderonke Pederson, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post intervention
Awards & highlights

Summary

"This trial aims to test a self-administered video-based program to reduce stigma and mistrust among Black adults with moderate to severe depression or anxiety."

Who is the study for?
This trial is for Black American or Black immigrant adults aged 18-45 who have depression or anxiety, own a smartphone with internet, and haven't been in regular healthcare or seen a mental health professional in the past year. It's not for those with certain impairments or severe mental health conditions like psychosis.Check my eligibility
What is being tested?
The study tests three different self-administered video interventions aimed at reducing stigma around mental illness and distrust in medical systems among Black adults suffering from moderate to severe depression or anxiety.See study design
What are the potential side effects?
Since this trial involves educational videos, there are no direct physical side effects expected. However, participants may experience emotional discomfort while discussing sensitive topics related to mental health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Release of Information Form
Treatment Inventory of Costs in Patients with Psychiatric Disorders
Secondary outcome measures
Group Help Seeking Questionnaire
Internalized Stigma of Mental Illness
Reported and Intended Behavior Scale
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Video Intervention 1Experimental Treatment1 Intervention
The video intervention #1 will involve videos of patients describing personal narratives of mental illness, treatment and recovery, and will be delivered over 4 weeks (with two booster sessions in week 6 and 12). Assessments will be completed over 12 months from date of randomization.
Group II: Video Intervention 2Active Control1 Intervention
The video intervention #2 will involve videos of patients describing personal narratives of mental illness, treatment and recovery, and will be delivered over 4 weeks (with two booster sessions in week 6 and 12). Assessments will be completed over 12 months from date of randomization.
Group III: Waitlist Video Intervention 3Placebo Group1 Intervention
After the completion of the 6-month waitlist period, the experimental video intervention will be provided. The intervention will involve videos of patients describing personal narratives of mental illness, treatment and recovery, and will be delivered over 4 weeks (with two booster sessions in week 6 and 12). The intervention offered after the waitlist period will follow video intervention 1 (experimental arm).

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,820 Previous Clinical Trials
2,692,729 Total Patients Enrolled
675 Trials studying Depression
256,799 Patients Enrolled for Depression
Massachusetts General HospitalLead Sponsor
2,955 Previous Clinical Trials
13,212,588 Total Patients Enrolled
186 Trials studying Depression
32,279 Patients Enrolled for Depression
Aderonke Pederson, MDPrincipal InvestigatorMassachuessets General Hospital
~60 spots leftby Jul 2026